查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356797

先天性腎上腺增生症診斷市場報告：至2030年的趨勢、預測與競爭分析

Congenital Adrenal Hyperplasia Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

先天性腎上腺增生症的診斷趨勢與預測

預計到2030年，全球先天性腎上腺增生症診斷市場將達到 8 億美元，2024年至2030年年複合成長率為 7.7%。該市場的主要促進因素是先天性腎上腺增生症的上升、政府資助和臨床試驗、醫療保健政策和償付的增加以及基因檢測技術進步的增加。全球先天性腎上腺增生症診斷市場的未來前景廣闊，醫院、診斷中心、門診手術中心和診所市場都有商機。

先天性腎上腺增生症診斷市場洞察

Lucintel 預測，由於醫療保健專業人員、患者和公眾對 CAH 的認知和教育不斷提高，典型的先天性腎上腺增生症將在預測期內經歷高速成長。

醫院可能仍然是最大的細分市場，因為人們越來越傾向於醫院護理，因為醫院可以輕鬆獲得良好的管理設施並受益於廣泛的基礎設施。

由於存在大量患者、人們對罕見遺傳疾病的認知不斷提高以及醫療基礎設施的改善，預計亞太地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球先天性腎上腺增生症診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球先天性腎上腺增生症診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 全球先天性腎上腺增生症診斷市場（依類型）
    • 典型的先天性腎上腺增生症
    • 非典型先天性腎上腺增生症
  • 以最終用途分類的全球先天性腎上腺增生症診斷市場
    • 醫院
    • 診斷中心
    • 門診手術中心
    • 診所
    • 其他

第4章 2018-2030年市場趨勢及預測分析（依地區）

  • 全球先天性腎上腺增生症診斷市場（依地區）
  • 北美先天性腎上腺增生症診斷市場
  • 歐洲先天性腎上腺增生症診斷市場
  • 亞太地區先天性腎上腺增生症診斷市場
  • 其他區域先天性腎上腺增生症診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球先天性腎上腺增生症診斷市場成長機會（依類型）
    • 全球先天性腎上腺增生症診斷市場成長機會（依最終用途）
    • 全球先天性腎上腺增生症診斷市場成長機會（依地區）
  • 全球先天性腎上腺增生症診斷市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球先天性腎上腺增生症診斷市場的產能擴張
    • 全球先天性腎上腺增生症診斷市場的合併、收購及合資企業
    • 認證和許可

第7章 主要企業概況

  • Medline Industries
  • Cook Medical
  • Cooper Surgical
  • Smiths Medical
  • Becton, Dickinson and Company
  • Rocket Medical
  • CENTOGENE NV
  • Eurofins Scientific
  • PerkinElmer
  • F. Hoffmann-La Roche.
簡介目錄

Congenital Adrenal Hyperplasia Diagnosis Trends and Forecast

The future of the global congenital adrenal hyperplasia diagnosis market looks promising with opportunities in the hospital, diagnostic center, ambulatory surgical center, and clinic markets. The global congenital adrenal hyperplasia diagnosis market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 7.7% from 2024 to 2030. The major drivers for this market are rising prevalence of congenital adrenal hyperplasia, growing government funding and clinical trials, and healthcare policies and reimbursement and increasing technological advancements in genetic testing.

A more than 150-page report is developed to help in your business decisions.

Congenital Adrenal Hyperplasia Diagnosis by Segment

The study includes a forecast for the global congenital adrenal hyperplasia diagnosis by type, end use, and region.

Congenital Adrenal Hyperplasia Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Classic Congenital Adrenal Hyperplasia
  • Non-classic Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Congenital Adrenal Hyperplasia Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Congenital Adrenal Hyperplasia Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies congenital adrenal hyperplasia diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the congenital adrenal hyperplasia diagnosis companies profiled in this report include-

  • Medline Industries
  • Cook Medical
  • Cooper Surgical
  • Smiths Medical
  • Becton, Dickinson And Company
  • Rocket Medical
  • Centogene N.V
  • Eurofins Scientific
  • Perkinelmer
  • F. Hoffmann-La Roche.

Congenital Adrenal Hyperplasia Diagnosis Market Insights

Lucintel forecasts that classic congenital adrenal hyperplasia is expected to witness higher growth over the forecast period due to growing awarness and education towards CAH among medical professionals, patients, and general public.

Hospitals will remain the largest segment due to increasing inclination towards hospital-based treatments, where they can easily access superior management facilities and benefit from enhanced infrastructure.

APAC is expected to witness highest growth over the forecast period due to presence of large pool of patients, increasing awareness towards rare genetic disorders, and improving healthcare infrastructure in the region.

Features of the Global Congenital Adrenal Hyperplasia Diagnosis Market

Market Size Estimates: Congenital adrenal hyperplasia diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Congenital adrenal hyperplasia diagnosis market size by type, end use, and region. in terms of value ($B).

Regional Analysis: Congenital adrenal hyperplasia diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the congenital adrenal hyperplasia diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the congenital adrenal hyperplasia diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the congenital adrenal hyperplasia diagnosis market size?

Answer: The global congenital adrenal hyperplasia diagnosis market is expected to reach an estimated $0.8 billion by 2030.

Q.2. What is the growth forecast for congenital adrenal hyperplasia diagnosis market?

Answer: The global congenital adrenal hyperplasia diagnosis market is expected to grow with a CAGR of 7.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the congenital adrenal hyperplasia diagnosis market?

Answer: The major drivers for this market are rising prevalence of congenital adrenal hyperplasia, growing government funding and clinical trials, and healthcare policies and reimbursement and increasing technological advancements in genetic testing.

Q.4. What are the major segments for congenital adrenal hyperplasia diagnosis market?

Answer: future of the global congenital adrenal hyperplasia diagnosis market looks promising with opportunities in the hospital, diagnostic center, ambulatory surgical center, and clinic markets.

Q.5. Who are the key congenital adrenal hyperplasia diagnosis market companies?

Answer: Some of the key congenital adrenal hyperplasia diagnosis companies are as follows:

  • Medline Industries
  • Cook Medical
  • Cooper Surgical
  • Smiths Medical
  • Becton, Dickinson and Company
  • Rocket Medical
  • CENTOGENE N.V
  • Eurofins Scientific
  • PerkinElmer
  • F. Hoffmann-La Roche.

Q.6. Which congenital adrenal hyperplasia diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that classic congenital adrenal hyperplasia is expected to witness higher growth over the forecast period due to growing awarness and education towards CAH among medical professionals, patients, and general public.

Q.7. In congenital adrenal hyperplasia diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to substantial patient population, the increasing incidence of congenital adrenal hyperplasia, well-established hospitals and health care infrastructure, and robust governmental backing for R&D initiatives. APAC is expected to witness highest growth over the forecast period due to presence of large pool of patients, increasing awareness towards rare genetic disorders, and improving healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the congenital adrenal hyperplasia diagnosis market by type (classic congenital adrenal hyperplasia and non-classic congenital adrenal hyperplasia), end use (hospitals, diagnostic centers, ambulatory surgical centers, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Congenital Adrenal Hyperplasia Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Congenital Adrenal Hyperplasia Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Congenital Adrenal Hyperplasia Diagnosis Market by Type
    • 3.3.1: Classic Congenital Adrenal Hyperplasia
    • 3.3.2: Non-classic Congenital Adrenal Hyperplasia
  • 3.4: Global Congenital Adrenal Hyperplasia Diagnosis Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Diagnostic Centers
    • 3.4.3: Ambulatory Surgical Centers
    • 3.4.4: Clinics
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Congenital Adrenal Hyperplasia Diagnosis Market by Region
  • 4.2: North American Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.2.2: North American Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
  • 4.3: European Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.3.1: European Congenital Adrenal Hyperplasia Diagnosis Market by Type: Classic Congenital Adrenal Hyperplasia and Non-classic Congenital Adrenal Hyperplasia
    • 4.3.2: European Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
  • 4.4: APAC Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.4.1: APAC Congenital Adrenal Hyperplasia Diagnosis Market by Type: Classic Congenital Adrenal Hyperplasia and Non-classic Congenital Adrenal Hyperplasia
    • 4.4.2: APAC Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
  • 4.5: ROW Congenital Adrenal Hyperplasia Diagnosis Market
    • 4.5.1: ROW Congenital Adrenal Hyperplasia Diagnosis Market by Type : Classic Congenital Adrenal Hyperplasia, and Non-classic Congenital Adrenal Hyperplasia
    • 4.5.2: ROW Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by Type
    • 6.1.2: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by End Use
    • 6.1.3: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Congenital Adrenal Hyperplasia Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Congenital Adrenal Hyperplasia Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Congenital Adrenal Hyperplasia Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Medline Industries
  • 7.2: Cook Medical
  • 7.3: Cooper Surgical
  • 7.4: Smiths Medical
  • 7.5: Becton, Dickinson and Company
  • 7.6: Rocket Medical
  • 7.7: CENTOGENE N.V
  • 7.8: Eurofins Scientific
  • 7.9: PerkinElmer
  • 7.10: F. Hoffmann-La Roche.